A Machine Learning Approach for Predicting Capsular Contracture after Postmastectomy Radiotherapy in Breast Cancer Patients.
capsular contracture
expander
immediate reconstruction
machine learning
prothesis
radiotherapy
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
05 Apr 2023
05 Apr 2023
Historique:
received:
09
02
2023
revised:
14
03
2023
accepted:
03
04
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
In recent years, immediate breast reconstruction after mastectomy surgery has steadily increased in the treatment pathway of breast cancer (BC) patients due to its potential impact on both the morpho-functional and aesthetic type of the breast and the quality of life. Although recent studies have demonstrated how recent radiotherapy techniques have allowed a reduction of adverse events related to breast reconstruction, capsular contracture (CC) remains the main complication after post-mastectomy radio-therapy (PMRT). In this study, we evaluated the association of the occurrence of CC with some clinical, histological and therapeutic parameters related to BC patients. We firstly performed bivariate statistical tests and we then evaluated the prognostic predictive power of the collected data by using machine learning techniques. Out of a sample of 59 patients referred to our institute, 28 patients (i.e., 47%) showed contracture after PMRT. As a result, only estrogen receptor status (ER) and molecular subtypes were significantly associated with the occurrence of CC after PMRT. Different machine learning models were trained on a subset of clinical features selected by a feature importance approach. Experimental results have shown that collected features have a non-negligible predictive power. The extreme gradient boosting classifier achieved an area under the curve (AUC) value of 68% and accuracy, sensitivity, and specificity values of 68%, 64%, and 74%, respectively. Such a support tool, after further suitable optimization and validation, would allow clinicians to identify the best therapeutic strategy and reconstructive timing.
Identifiants
pubmed: 37046969
pii: healthcare11071042
doi: 10.3390/healthcare11071042
pmc: PMC10094026
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministry of Health
ID : Ricerca Finalizzata 2018 deliberation n.812/2020
Références
Breast Cancer. 2020 Jul;27(4):716-723
pubmed: 32162180
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
Breast. 2021 Apr;56:7-13
pubmed: 33517043
JAMA Surg. 2017 Sep 20;152(9):e172338
pubmed: 28724125
J Surg Oncol. 2020 Apr;121(5):766-776
pubmed: 31879978
Rep Pract Oncol Radiother. 2021 Sep 30;26(5):730-739
pubmed: 34760307
J Reconstr Microsurg. 2017 Jun;33(5):312-317
pubmed: 28235218
Br J Plast Surg. 1997 Feb;50(2):99-105
pubmed: 9135425
Eur J Surg Oncol. 2000 Feb;26(1):17-9
pubmed: 10718173
J Natl Compr Canc Netw. 2009 Feb;7(2):122-92
pubmed: 19200416
Plast Reconstr Surg. 1995 Oct;96(5):1119-23; discussion 1124
pubmed: 7568488
Breast. 2021 Feb;55:37-44
pubmed: 33316582
Restor Dent Endod. 2017 May;42(2):152-155
pubmed: 28503482
J Mater Sci Mater Med. 2018 Mar 6;29(3):27
pubmed: 29511877
Plast Reconstr Surg. 2006 Feb;117(2):359-65
pubmed: 16462313
Plast Reconstr Surg. 2022 Jan 1;149(1):1e-12e
pubmed: 34758003
J Insur Med. 2017;47(1):31-39
pubmed: 28836909
Sci Rep. 2019 Aug 6;9(1):11399
pubmed: 31388036
Med Oncol. 2019 Apr 25;36(6):48
pubmed: 31028487
Stat Med. 2018 Nov 30;37(27):3991-4006
pubmed: 29984411
Radiother Oncol. 2010 Mar;94(3):286-91
pubmed: 20199818
Plast Reconstr Surg. 2018 Mar;141(3):566-577
pubmed: 29481388
Front Oncol. 2019 Apr 09;9:243
pubmed: 31024845
Lancet Oncol. 2017 Dec;18(12):e742-e753
pubmed: 29208440